Development and laboratory scale production of inactivated triple ND+AI (H9N2)+IBD vaccine

Document Type : Full Research Paper

Authors

Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj, Iran

Abstract

Newcastle disease (ND), avian influenza (AI) and infectious bursal disease (IBD) cause severe damage to the poultry industry. Vaccination is often used to prevention or control the spread of poultry diseases. Inactivated vaccines are used to produce the uniform antibody titer, the increase antibody levels and its shelf life. In this study, the ND, AI and IBD triple inactivated vaccine was designed and prepared in laboratory scale. Then its immunization potential was evaluated in SPF chickens. To produce the triple vaccine, the ND V4, avian AI H9N2 and IBD 07IR standard strains were separately propagated in embryonated eggs. The viral suspensions were inactivated after virus titration. Different amounts of each virus were considered as a dose and introduced as a vaccine after standard control tests. The prepared vaccine was injected along with an imported vaccine to different groups of SPF chickens and HI, VN and ELISA tests were performed on serum samples. The HI titer was 7.6 for ND and 6.7 for AI. In the VN test, the neutralization index for IBD was 3.5. In the ELISA test, the antibody titer against ND was 8481, for AI 7569 and for IBD 3108. These data did not differ significantly from the results of the imported vaccine. The results showed that the developed triple inactivated vaccine provided good immunity and also had no side effects for SPF chickens.

Keywords

References

1- Afonso, C., P. J. Miller., C. H. Grund., G. Koch., B. Peeters., P. W. Selleck and G. B. Srinivas. 2018. Newcastle disease (infection with Newcastle disease virus).  pp. 964-985, In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Office International des Epizooties, World Organization for Animal Health, Paris.
2- Alkie, T. N., A. Yitbarek., D. C. Hodgins., R. R. Kulkarni., K. Taha-Abdelaziz and S. Sharif. 2019. Development of innate immunity in chicken embryos and newly hatched chicks: A disease control perspective. Avian Pathology, 48: 288-310.
3- Awate, S., L. A. B. Babiuk and G. Mutwiri. 2013. Mechanisms of action of adjuvants. Frontiers in Immunology, 4: 1-10.
4- Brun, A. 2016. Vaccines and vaccination for veterinary viral diseases: a general overview. Vaccine Technologies for Veterinary Viral Diseases, 1349: 1-24.
5- Dey, S., D. C. Pathak., N. Ramamurthy., H. K. Maity and M. M. Chellappa. 2019. Infectious bursal disease virus in chickens: prevalence, impact, and management strategies. Veterinary Medicine: Research and Reports, 10: 85-97.
6- Dupuis, L., S. Ascarateil., J. Aucouturier and V. Ganne. 2006. SEPPIC vaccine adjuvants for poultry. Annals of the New York Academy of Sciences, 1081: 202-205.
7- Eterradossi, N. and Y. M. Saif. 2020. Infectious Bursal Disease.  pp: 257-283. In: D. Swayne (ed.), Diseases of poultry. John Wiley & Sons, Inc, New York. 
8- Eterradossi, N. and Y. M. Saif. 2018. Infectious bursal disease (Gumboro disease).  pp: 931-951. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Office International des Epizooties, World Organization for Animal Health, Paris. 
9- Hincke, M. T., M. Da Silva., N. Guyot., J. Gautron., M. D. McKee., R. Guabiraba-Brito and S. Réhault-Godbert. 2019. Dynamics of structural barriers and innate immune components during incubation of the avian egg: critical interplay between autonomous embryonic development and maternal anticipation. Journal of Innate Immunity, 11: 111-124.
10- James, N. 2017. Fenner's Veterinary Virology. N. J. Maclachlan and E. J. Dubovi, Elsevier Academic Press, London.
11- Jeurissen, S. H., A. G. Boonstra_Blom., S. O. Al_Garib., L. Hartog and G. Koch. 2000. Defence mechanisms against viral infection in poultry: a review. Veterinary Quarterly, 22: 204-208.
12- Kim, S. M., Y. I. Kim., S. J. Park., E. H. Kim., H. I. Kwon., Y. J. Si., I. W. Lee., M. S. Song and Y. K. Choi. 2017. Vaccine efficacy of inactivated, chimeric hemagglutinin H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy. Journal of Virology, 91: 1-17.
13- Marangon, S. and L. Busani. 2007. The use of vaccination in poultry production. Revue Scientifique et Technique-Office International des Epizooties, 26: 265-274.
14- Meeusen, E. N., J. Walker., A. Peters., P. P. Pastoret and G. Jungersen. 2007. Current status of veterinary vaccines. Clinical Microbiology Reviews, 20: 489-510.
15- Müller, H., E. Mundt., N. Eterradossi and M. R. Islam. 2012. Current status of vaccines against infectious bursal disease. Avian Pathology, 41: 133-139.
16- Niewiesk, S. 2014. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Frontiers in Immunology, 5: 1-15.
17- Palya, V. 1991. Manual for the production of Marek's disease, Gumboro disease and inactivated Newcastle disease vaccines. Food & Agriculture Organization, Rome.
18- Patti J. M., P. Koch and G. Section. 2020. Newcastle Disease. pp:  112-128. In: D. Swayne (ed.), Diseases of poultry. John Wiley & Sons, Inc, New York.
19- Swane, D. and I. Brown. 2018. Avian influenza (infection with avian influenza virus). pp: 821-843. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Office International des Epizooties, World Organization for Animal Health. Paris.
20- Swayne, D., D. L. Suarez and L. D. Sims. 2020. Influenza. pp:  210-256. In: D. Swayne (ed.), Diseases of Poultry. John Wiley & Sons, Inc, New York.
21- Van Boven, M., A. Bouma., T. H. Fabri., E. Katsma., L. Hartog and G. Koch. 2008. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathology, 37: 1-5.
 

Files

History

  • Receive Date: 01 June 2021
  • Revise Date: 04 August 2021
  • Accept Date: 23 August 2021

Share

How to cite

Statistics